Bombax ceiba Linn. : A review of its phytochemistry and pharmacology
AUTHORS : Santosh Kumar Maurya, NK Verma, Dinesh Kumar Verma DOI No. : NA DOI Link. : NA Background: Since ancient time plants are main sources of human need in terms of food, shelter or medicine. Bombax ceiba L. (Fam: Bombacaceae) is an important plant in South East Asian countries not only for medicinal values but also for its economical importance. It a large, perennial tree available in Asia, Africa, Australia and India ascending the hills up to 1,500 m.
Aim of the review: The purpose of this review is to exhibit up-to-date and comprehensive information about phytochemistry, pharmacological activities of the plant and has an insight into the opportunities for the future research and development of plant. Materials and methods: A bibliographic investigation was performed on all the available information regarding B. ceiba via electronic search (using Pubmed, SciFinder, Scopus, Scirus, Google Scholar, JCCC@INSTIRC, Web of Science and a library search for articles published in peer-reviewed journals).
Conclusion: Various phytoconstituents from the plant has been reported, which includes mangiferin, quercetin, shamimin, shamimoside, β–sitosterol, taraxeryl acetate, lupeol, simalin a, simalin b, shamimicin, bombamalones a–d, bombaxquinone b, bombamaloside and bombasin. The plant was evaluated for a number of activities such as analgesic, anthelmintic, anti cancer, antibacterial, antidiabetic, anti-inflammatory, hepatoprotective, immunomodulatory, cardioprotective, antiulcer, anti-diarrhoeal, antiviral, hypotensive activity. Present review demonstrates that the B. ceiba may serve as a good source of medicines in future. Majority of therapeutic claims for the plants in the various traditional medicines have been confirmed through experimental pharmacology.